Open AccessA randomized controlled trial of imipramine in patients with irritable bowel syndrome
Author(s) -
Heitham AbdulBaki,
Ihab I. El Hajj,
Lara M. El-Zahabi,
Cecilio Azar,
Elie Aoun,
Assaad Skoury,
Hani F. Chaar,
Ala Sharara
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.3636
Subject(s) - imipramine , medicine , placebo , irritable bowel syndrome , adverse effect , randomized controlled trial , gastroenterology , pathology , alternative medicine
To study the efficacy of low-dose imipramine in relieving symptoms associated with the irritable bowel syndrome (IBS).